GlassScriptPhysician profile
Reza Shafee
NPI 1275586992
$2,391.31
in general payments reported to CMS, 2019-2025
17 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $63.26 · 2021: $154 · 2022: $621 · 2023: $332 · 2024: $259 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $528.68 | 2019-2023 | Lo Loestrin Fe |
| Merz North America, INC. | $504.51 | 2019-2022 | |
| Allergan, INC. | $295.25 | 2019 | |
| Galderma Laboratories, L.P. | $242.12 | 2021-2024 | |
| Biogen, INC. | $149.82 | 2025 | Zurzuvae |
| Pfizer INC. | $131.28 | 2021-2024 | |
| Amarin Pharma, INC. | $124.12 | 2019 | |
| Roche Diagnostics Corporation | $91.31 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $74.09 | 2024-2025 | Myfembree |
| Ethicon US, LLC | $69.85 | 2022 | |
| Coloplast Corp | $66.58 | 2022 | |
| Astellas Pharma US INC | $31.96 | 2024 | Veozah |
| Aspira Women'S Health INC | $23.62 | 2022 | |
| Medical Device Business Services, INC. | $19.26 | 2023 | Vistaseal |
| Smith+Nephew, INC. | $15.37 | 2023 | Pico 7 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.10 | 2019 | |
| Meditrina | $9.39 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Shafee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.